Deviations in RSV epidemiological patterns and population structures in the United States following the COVID-19 pandemicEstefany Rios-Guzman, Judd F. Hultquist, Lacy M. Simons et al.|Nature Communications|2024Cited by 83
Distinctive evolution of alveolar T cell responses is associated with clinical outcomes in unvaccinated patients with SARS-CoV-2 pneumoniaNikolay S. Markov, Helen K. Donnelly, Elizabeth S. Malsin et al.|Nature Immunology|2024Cited by 16
The impact of remdesivir on SARS-CoV-2 evolution in vivoTed Ling-Hu, Judd F. Hultquist, Lacy M. Simons et al.|JCI Insight|2025Cited by 6
Altered RSV Epidemiology and Genetic Diversity Following the COVID-19 PandemicJudd F. Hultquist, Ramón Lorenzo-Redondo, Estefany Rios-Guzman et al.|Research Square|2023Cited by 5
Integration of individualized and population-level molecular epidemiology data to model COVID-19 outcomesTed Ling-Hu, Judd F. Hultquist, Lacy M. Simons et al.|Cell Reports Medicine|2024Cited by 2